ACRS vs HAS · rev $18.7M vs P/E 25, rev $4.75B
Aclaris Therapeutics Inc (ACRS) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported ACRS revenue for 2024-12-31 was $18.7M. Net income was -$132.1M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. ACRS currently screens at market cap $615.9M.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
ACRS currently screens at market cap $615.9M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the ACRS and HAS stock pages for the full models.
Not investment advice.